Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-05-23 @ 9:25 AM
Study NCT ID:
NCT06288334
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2024-02-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
Sponsor:
Peking University Third Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PUTH PD_V 1.2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None